According to the literature, PTEN-deleted tumors are likely to be PIK3CB-dependent; a coexistent loss and mutation of PTEN and PIK3CB might increase PIK3 pathway output and indicate PCa with AR signaling inhibition. The gene discussed is PTEN; the disease is posterior cortical atrophy.